Astrana Health, Inc (ASTH) PT Raised to $45 at Baird

May 8, 2026 7:55 AM

Baird analyst Michael Ha raised the price target on Astrana Health, Inc (NASDAQ: ASTH) to $45.00 (from $40.00) while maintaining a Outperform rating.

No results found